Silo Pharma Inc
(SILO)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2019 | 12-2018 | 12-2017 | 12-2016 | 12-2015 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 112 | 337 | 295 | 579 | 0 |
| Marketable Securities | 9 | 228 | 1,320 | 635 | 0 |
| Receivables | N/A | N/A | N/A | 59 | 0 |
| Inventories | 156 | 27 | N/A | N/A | 0 |
| Other current assets | 200 | 0 | 0 | 0 | 0 |
| TOTAL | $494 | $626 | $1,641 | $1,300 | $0 |
| Non-Current Assets | |||||
| Intangibles | 0 | 29 | 0 | 0 | 0 |
| Other Non-Current Assets | 0 | 200 | 0 | 0 | 0 |
| TOTAL | $N/A | $229 | $N/A | $N/A | $N/A |
| Total Assets | $494 | $855 | $1,641 | $1,300 | $0 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 62 | 22 | N/A | N/A | 0 |
| Accounts payable and accrued liabilities | 55 | 26 | 38 | 53 | 0 |
| TOTAL | $117 | $48 | $38 | $53 | $0 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 400 | 400 | 400 | 400 | 0 |
| TOTAL | $400 | $400 | $400 | $400 | $N/A |
| Total Liabilities | $517 | $448 | $438 | $453 | $0 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 23,604 | N/A | N/A | N/A | N/A |
| Common Shares | 2 | 2 | 5 | 5 | 0 |
| Retained earnings | -2,656 | -1,643 | N/A | N/A | 0 |
| Other shareholders' equity | 0 | 0 | -673 | -1,030 | 0 |
| TOTAL | $-23 | $407 | $1,203 | $847 | $0 |
| Total Liabilities And Equity | $494 | $855 | $1,641 | $1,300 | $0 |